Journal
TRANSPLANTATION AND CELLULAR THERAPY
Volume 28, Issue 9, Pages -Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtct.2022.06.011
Keywords
Rehabilitation; Allogeneic hematopoietic transplantation; CT; Muscle
Categories
Funding
- LOTTE Foundation
- Program for the Development of Next-Generation Leading Scientists with Global Insight (L-INSIGHT) - Ministry of Education, Culture, Sports, Science and Technology of Japan
Ask authors/readers for more resources
This retrospective cohort study used computed tomography scans to evaluate the quality and quantity of skeletal muscle in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). The study found that radiographic density (RD) was an independent risk factor for poor overall survival, while psoas muscle mass index (PMI) was not significant. Decreased RD and reduced 6-min walking distance before transplantation were significant factors in increased nonrelapse mortality.
During clinical courses involving treatment with allogeneic hematopoietic stem cell transplantation (allo-HSCT), multidisciplinary patient assessment including physical function is indispensable, and quantitative skeletal muscle loss is a poor prognostic marker. Deteriorating quality of muscle from intramuscular adipose tissue degeneration can be important as well, because many patients are cachexic or sarcopenic before allo-HSCT, although this approach has not yet been used in such patients. We conducted this retrospective cohort study to evaluate the quality as well as quantity of skeletal muscle using computed tomography (CT) scans. The psoas muscle mass index (PMI) and radiographic density (RD) calculated by cross-sectional area and averaged CT values of the psoas major muscle at the umbilical level were used to determine the quantity and quality of muscle, respectively. A total of 186 adult patients, ranging in age from 17 to 68 years (median, 49 years), were included in this study, with 46 (24.7%) assigned to the lower PMI group and 49 (26.3%) assigned to the lower RD group. Low RD was identified as an independent risk factor for poor overall survival after allo-HSCT (adjusted hazard ratio [HR], 2.54; P < .01), whereas PMI was not significant. Decreased RD along with a reduced 6-min walking distance before transplantation were significant factors in increased nonrelapse mortality (HR, 2.69; P = .01). This study is the first to suggest the use of a qualitative skeletal muscle index to serve as a prognostic indicator following allo-HSCT. RD should be included in pretransplantation screening parameters, and approaches that include rehabilitation focused on improving both muscle quality and quantity may improve the prognosis of allo-HSCT. (C) 2022 The American Society for Transplantation and Cellular Therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available